October
18, 2006
ALS-Related Findings Reported at Meeting
At the 36th annual meeting of the
Society of Neuroscience, held this
week in Atlanta, scientists noted
two possible toxins they believe should
be pursued for their possible role
in amyotrophic
lateral sclerosis (ALS) and
reported that blocking a protein that
inhibits muscle growth delays the
onset of ALS symptoms in mice with
an ALS-causing genetic mutation.
A group from the University of British
Columbia in Vancouver, Canada, reported
that aluminum salts used in anthrax
vaccinations during the Persian Gulf
War of 1991 might be playing a role
in the increased incidence of ALS
in Gulf War veterans. Mice treated
with an aluminum-based compound used
in the vaccines developed motor dysfunction,
lost motor neurons (the cells involved
in ALS) and showed signs of nervous
system inflammation.
Another Canadian group, with scientists
from the University of British Columbia
and McGill University in Montreal,
reported they’ve identified
the likely toxins in cycad seeds,
long associated with excessive numbers
of ALS cases on Guam. They say the
culprits are molecules called sterol
glucosides. Mice fed these molecules
for 10 weeks lost 30 percent to 45
percent of their spinal cord motor
neurons.
Researchers from the University of
Southern California in Los Angeles
reported that mice bred with a genetic
mutation in the SOD1 gene known to
cause ALS and also bred not
to produce a protein called myostatin,
known to limit muscle growth, fared
better than mice with the SOD1 mutation
but with intact myostatin genes. The
mice without myostatin did better
than the other mice on tests of motor
function, and they showed better preservation
of nerve and muscle cells at various
time points. Life span in the male
mice didn’t increase, but two
female mice showed an average increase
in life span of 21 percent compared
to a myostatin-producing littermate.
A medication to block myostatin is
in clinical trials for adult forms
of muscular dystrophy.
|